News and Updates
Please check in from time to time for updates!!!
Please scroll down to view all the information listed below.
March 20, 2013 - Papillon PRA1 testing available
March 18, 2013 - Primary Lens Luxation Testing available for multiple breeds
December 4, 2012 - Joint statement released between OptiGen and InGen.
October 12, 2012 - Joint statement released between OptiGen and Genindexe.
June 26, 2012 - OptiGen is awarded ISO17025 Accreditation!
August 1, 2011 - News Release for our U.S. customers
July 7, 2011 - Trapped Neutrophil Syndrome Testing (TNS) Available
June 20, 2011 - 2 New Tests for Australian Shepherds
August 31, 2010 - Important Progress in Patent Lawsuit - Joint statement released.
June 29, 2010 - Neuropathy in the Greyhound.
June 17, 2010 - Cone Rod Dystrophy in American Pit Bull Terrier (crd2) & Glen of Imaal Terrier (crd3).
May 14, 2010 - Cone Degeneration in Alaskan Malamutes.
March 8, 2010 - New IC13 for Improper Coat in Portuguese Water dog available
February 12, 2010 - Important Progress in Patent Lawsuit - Joint statement released.
October 2009 - Beginning in October 2009, all samples from India should be directed to GTG...
May 1, 2009 - Important message concerning second lawsuit filed to protect patents.
December 31, 2008 - June 30, 2009 - Offer has ended...
OptiGen's Anniversary Special - Celebrating 10 years of service!
November 19, 2008 -
Cerebellar Ataxia test now available for American Staffordshire Terriers - OptiGen is pleased to partner with Antagene in France to assist North American owners of American Staffordshire Terriers who wish to test their dog’s DNA for Cerebellar Ataxia. To make this test more convenient for North American clients, OptiGen is serving as an agent for Antagene, by rendering blood or cheek swab samples into DNA and shipping the DNA to Antagene. Antagene owns the international license for testing Cerebellar Ataxia (patent pending) in the American Staffordshire Terrier and will perform the DNA testing in their laboratory in France. OptiGen will obtain the results of the test from Antagene as soon as the tests are completed and send reports to the owners.
October 24, 2008 -
Test for rcd2-PRA now available for Collies - It has been a long time coming but rough and smooth collie breeders can now celebrate the news that a definitive DNA test for PRA is available for their breeds. Thanks to years of dedicated work by researchers in the laboratories of Dr. Greg Acland and Dr. Gus Aguirre, and aided by early support from Morris Animal Foundation and the Collie Health Foundation, the mutation responsible for the collie PRA called rod cone dysplasia type 2 (rcd2) has been identified. OptiGen has been granted exclusive rights worldwide to offer this test by Cornell University and the test is now available at OptiGen.
September 23, 2008 -
Normal to Affected Offspring Tested at Reduced Prices
July 25, 2008 -
Test for Inherited RD/OSD in Labradors & Samoyeds Now Available
March 20, 2008
March 3, 2008
Testanforderungsformulare sind jetzt auch in deutscher Übersetzung
February 27, 2008
OptiGen Health Registry Update 2/27/08 Finnish Tollers
February 14, 2008
DKK Health Registry Announcement
January 17, 2008
News Update on prcd-PRA Testing in Europe
January 8, 2008
Traduction en français des formulaires de demande de tests
December 7, 2007
Normal to Normal Offspring Tested at Reduced Prices
April 6, 2007
Cheek Swabs Now Accepted by OptiGen
January 8, 2007
Genetic test for CMR - Canine Multi-focal Retinopathy for Mastiffs: (Old English, Bullmastiff, Dogue de Bordeaux--French Mastiff), Great Pyrenees and Coton de Tulear now available
December 12, 2006
FN - Familial Nephropathy test for English Cocker Spaniels
November 27, 2006
Genetic test for prcd-PRA now available for Spanish Water Dog & Australian Shepherd
August 24, 2006
OFA Registrations Resume
August 1, 2006
Genetic test for prcd-PRA announced for Kuvasz
June 19, 2006
Reports Get New Look - July 1, 2006
We're giving the OptiGen test REPORT a NEW LOOK....
May 25, 2006
Testing in Australia, New Zealand and Japan
New information on source of testing.
April 17, 2006
CEA - Collie Eye Anomaly Test for Tollers
The OptiGen genetic test for CEA in the Toller is now available and can be done on Toller samples submitted to Optigen previously for prcd-PRA testing. Please read about these details at this link. Detailed information about the discovery of CEA in the Nova Scotia Duck Tolling Retriever is reported by the Health and Genetics Committee of the USA NSDTRC on its website http://www.nsdtrc-usa.org/CEAIntro.htm.
July 25, 2005
CL (NCL - Neuronal Ceroid Lipofuscinosis) Test for Border Collies
The genetic test for Neuronal Ceroid Lipofuscinosis in Border Collies is offered by OptiGen as of July 25, 2005. The CL test can be done on Border Collie samples submitted to OptiGen previously for CEA/CH testing. Please read about the details at this link.
June 1, 2005
New Mutation Test for prcd PRA Is Now Available
OptiGen, LLC, proudly announces identification of the gene causing canine prcd-PRA (progressive rod-cone degeneration form of Progressive Retinal Atrophy). The cause of this inherited blinding disease, occurring in at least a dozen purebreeds, is one specific mutation in the coding sequence of the gene. OptiGen now offers a direct gene mutation test (mutation test) to detect the prcd-PRA status of any dog among affected breeds.
OptiGen Tests PRA Affected Dogs at No Cost
It is EXTREMELY important to test as many PRA-affected dogs in each breed as possible. To promote this, OptiGen will test, at no charge, affected dogs from each of the 16 breeds with a known genetic form of PRA.
OptiGen, LLC, a veterinary diagnostic, service and research laboratory offers DNA testing to detect genetic disease in dogs - providing the ultimate advantage for canine breeding programs. Visit our homepage, browse our test offerings.